SummaryVitamin D deficiency is associated with increased incidence and severity of various immuneâmediated diseases. Active vitamin D (1Îą,25âdihydroxyvitamin D3; 1,25(OH)2D3) upâregulates CD4+ Tâcell expression of the purine ectonucleotidase CD39, a molecule that is associated with the generation of antiâinflammatory adenosine. Here we aimed to investigate the direct impact of 1,25(OH)2D3 on expression of the downstream ectoâ5â˛ânucleotidase CD73 by human CD4 T cells, and components of the transforming growth factorâβ (TGFâβ) pathway, which have been implicated in the modulation of CD73 by murine T cells. At 10â8 to 10â7
m, 1,25(OH)2D3 significantly increased expression of CD73 on peripheral human CD4+ T cells. Although 1,25(OH)2D3 did not affect the mRNA expression of latent TGFâβ
1, 1,25(OH)2D3 did upâregulate expression of TGFâβâassociated molecules [latencyâassociated peptide (LAP), glycophorin A repetitions predominant (GARP), GP96, neuropilinâ1, thrombospondinâ1 and Îąv integrin] which is likely to have contributed to the observed enhancement in TGFâβ bioactivity. CD73 was highly coâexpressed with LAP and GARP following 1,25(OH)2D3 treatment, but unexpectedly, each of these cell surface molecules was expressed primarily on CD4+ Foxp3â T cells, rather than CD4+ Foxp3+ T cells. Notably, neutralization of TGFâβ significantly impaired 1,25(OH)2D3âmediated induction of CD73. Collectively, we show that 1,25(OH)2D3 enhances expression of CD73 on CD4+ Foxp3â T cells in a process that is at least partially TGFâβâdependent. These data reveal an additional contributing mechanism by which vitamin D may be protective in immuneâmediated disease.